EDAP to Participate in the Piper Sandler 36th Annual Healthcare Conference
EDAP TMS (Nasdaq: EDAP), a leader in robotic energy-based therapies, announced its participation in the Piper Sandler 36th Annual Healthcare Conference in New York City. CEO Ryan Rhodes will engage in a fireside discussion and conduct one-on-one investor meetings during the event, scheduled for December 3-5, 2024. The fireside chat is set for Tuesday, December 3rd, from 4:00-4:25 PM EST. Both live and archived webcasts will be available through the company's investor relations website section.
EDAP TMS (Nasdaq: EDAP), un leader nelle terapie robotiche basate sull'energia, ha annunciato la sua partecipazione alla 36ª Conferenza Sanitaria Annuale di Piper Sandler a New York. Il CEO Ryan Rhodes parteciperà a una discussione informale e condurrà incontri one-to-one con gli investitori durante l'evento, in programma dal 3 al 5 dicembre 2024. La chat si terrà martedì 3 dicembre, dalle 16:00 alle 16:25 EST. Saranno disponibili sia webcast in diretta che registrati nella sezione delle relazioni con gli investitori del sito web della società.
EDAP TMS (Nasdaq: EDAP), líder en terapias robóticas basadas en energía, anunció su participación en la 36ª Conferencia Anual de Salud de Piper Sandler en Nueva York. El CEO Ryan Rhodes participará en una charla informal y llevará a cabo reuniones individuales con inversores durante el evento, programado del 3 al 5 de diciembre de 2024. La charla se llevará a cabo el martes 3 de diciembre, de 4:00 a 4:25 PM EST. Se podrán encontrar tanto retransmisiones en vivo como grabadas a través de la sección de relaciones con inversores del sitio web de la empresa.
EDAP TMS (Nasdaq: EDAP), 로봇 에너지 기반 치료의 선두주자,는 뉴욕에서 열리는 파이퍼 샌들러 제36회 연례 헬스케어 컨퍼런스에 참여한다고 발표했습니다. CEO Ryan Rhodes는 행사 기간 동안 1대1 투자자 회의를 진행하고, 화재측 대화에 참여할 예정이며, 이 행사는 2024년 12월 3일부터 5일까지 예정되어 있습니다. 화재측 대화는 12월 3일 화요일 오후 4시부터 4시 25분 EST까지 진행됩니다. 회사의 투자자 관계 웹사이트 섹션을 통해 생중계 및 기록된 웹캐스트를 이용할 수 있습니다.
EDAP TMS (Nasdaq: EDAP), un leader dans le domaine des thérapies robotiques basées sur l'énergie, a annoncé sa participation à la 36e Conférence Annuelle sur la Santé de Piper Sandler à New York. Le PDG Ryan Rhodes participera à une discussion informelle et organisera des réunions individuelles avec des investisseurs pendant l'événement, prévu du 3 au 5 décembre 2024. La discussion informelle aura lieu le mardi 3 décembre, de 16h00 à 16h25 EST. Des webcasts en direct et enregistrés seront disponibles dans la section des relations avec les investisseurs du site web de la société.
EDAP TMS (Nasdaq: EDAP), ein führendes Unternehmen im Bereich roboterbasierter Energie-Therapien, gab seine Teilnahme an der 36. Jährigen Gesundheitskonferenz von Piper Sandler in New York City bekannt. Der CEO Ryan Rhodes wird an einer informellen Diskussion teilnehmen und individuelle Investorenmeetings während der Veranstaltung durchführen, die vom 3. bis 5. Dezember 2024 stattfindet. Das Gespräch findet am Dienstag, den 3. Dezember, von 16:00 bis 16:25 Uhr EST statt. Sowohl Live- als auch archivierte Webcasts werden über den Bereich für Investorenbeziehungen der Unternehmenswebsite verfügbar sein.
- None.
- None.
LYON, France, November 27, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced that Ryan Rhodes, Chief Executive Officer of EDAP TMS, is scheduled to participate in a fireside discussion and host 1x1 investor meetings at the upcoming Piper Sandler 36th Annual Healthcare Conference, which is taking place from December 3-5, 2024, in New York City.
Presentation Details:
Piper Sandler 36th Annual Healthcare Conference
Format: Fireside Discussion
Date: Tuesday, December 3rd
Time: 4:00-4:25 PM EST
Location: New York City
The live and archived webcast of the presentations can be accessed in the Investors section of the Company’s website here.
About EDAP TMS SA
A recognized leader in the global therapeutic ultrasound market, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various pathologies using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in Europe and in the U.S. as an answer to all requirements for ideal prostate tissue ablation. With the addition of the ExactVu™ Micro-Ultrasound device, EDAP TMS is now the only company offering a complete solution from diagnostics to focal treatment of Prostate Cancer. EDAP TMS also produces and distributes other medical equipment including the Sonolith® i-move lithotripter and lasers for the treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL). For more information on the Company, please visit http://www.edap-tms.com, us.hifu-prostate.com and www.focalone.com.
Company Contact
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
bconfort@edap-tms.com
Investor Contact
John Fraunces
LifeSci Advisors, LLC
(917) 355-2395
jfraunces@lifesciadvisors.com
FAQ
When is EDAP presenting at the Piper Sandler Healthcare Conference 2024?
What type of presentation will EDAP (NASDAQ: EDAP) give at the Piper Sandler conference?
How can investors watch EDAP's presentation at the Piper Sandler Healthcare Conference?
Who will represent EDAP at the Piper Sandler Healthcare Conference 2024?
